Information Library

Results for: Faster product development - Clinical Monitoring

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • KoNECT & Quintiles Partner to Advance Clinical Research

    Press Release — May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India

    Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.

  • Using Real-Time Data to Drive Better Decisions, Faster

    White Paper — September 30, 2010
    This white paper examines the advantages afforded by access to real-time data during the course of a clinical trial.

  • Unrivalled Global Reach

    Case Study — February 22, 2010
    Failure was never an option with Quintiles’ guiding this complex global chronic heart failure study.

  • QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD

    Press Release — December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.

  • Sub-Saharan Africa Phase II/III Fact Sheet

    Brochure — July 29, 2009
    Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.

  • Antibiotic Safety Assessment

    Case Study — March 25, 2009
    A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.

  • Monitoring for Quality

    White Paper — May 22, 2008
    Scott Cooley, Executive Director, Phase IIIb/IV Product Management, Quintiles, discusses innovative and traditional resources in a risk-based monitoring program.

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences